ADVERTISEMENT

 

Press Releases

 

29

Oct

2024

Statement on pharmacy closures and ECAPS legislation

Washington, DC—APhA is deeply concerned about the ongoing reports of pharmacy closures, which primarily highlight the inconvenience of losing a local prescription source. However, this issue extends far beyond inconvenience; it jeopardizes access to trusted pharmacists, particularly in rural and underserved communities

Comments (0)
Number of views (1815)
Article rating: No rating

21

Aug

2024

APhA and NASPA release tenth PWWR report and learnings

WASHINGTON, DC— Today the American Pharmacists Association (APhA) and the National Alliance of State Pharmacy Associations (NASPA) released the tenth installment of the Pharmacy Workplace and Well-being Reporting (PWWR) trends and learnings report series.

Comments (0)
Number of views (1179)
Article rating: No rating

16

Aug

2024

APhA announces campaign to fight harmful practices of PBM's

WASHINGTON, DC – Today, the American Pharmacists Association (APhA) announced the start of a new consumer-focused campaign to end the harmful practices of pharmacy benefit managers (PBMs). 

Comments (0)
Number of views (1721)
Article rating: No rating

3

Oct

2023

American Pharmacists Month 2023: Celebrating the vital role of pharmacists in public health

WASHINGTON, DC (October 3, 2023) — American Pharmacists Month (APhM) is here, and the American Pharmacists Association (APhA) invites everyone to join in celebrating the essential contributions of pharmacists to health care and their communities.

Comments (0)
Number of views (6770)
Article rating: No rating

20

Mar

2023

APhA applauds new federal bipartisan PBM legislation

The American Pharmacists Association (APhA) applauds the introduction of the Drug Price Transparency in Medicaid Act, which would reign in PBMs’ unfair and anticompetitive business practices that are harming the viability of our nation’s pharmacies.

Comments (0)
Number of views (2898)
Article rating: No rating
RSS
Advertisement
Advertisement